Faron Pharmaceuticals Oy (LON:FARN) Shares Cross Below 50 Day Moving Average – What’s Next?

Faron Pharmaceuticals Oy (LON:FARN)’s share price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 184.50 and traded as low as GBX 164.50. Faron Pharmaceuticals Oy shares last traded at GBX 167.98, with a volume of 11,924 shares.

Faron Pharmaceuticals Oy Price Performance

The firm has a market cap of £191.33 million, a P/E ratio of -6.22 and a beta of 0.36. The company has a fifty day moving average of GBX 184.50 and a 200-day moving average of GBX 196.66. The company has a debt-to-equity ratio of 922.55, a current ratio of 1.45 and a quick ratio of 1.09.

About Faron Pharmaceuticals Oy

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.